Literature DB >> 2403652

Prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

S Y Pang1, M S Pollack, R N Marshall, L Immken.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2403652     DOI: 10.1056/NEJM199001113220207

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

Review 1.  Prenatal diagnosis of enzyme defects--an update.

Authors:  B Winchester; E Young
Journal:  Arch Dis Child       Date:  1991-04       Impact factor: 3.791

2.  Early dexamethasone treatment induces placental apoptosis in sheep.

Authors:  Thorsten Braun; Wenbin Meng; Hongkai Shang; Shaofu Li; Deborah M Sloboda; Loreen Ehrlich; Karolin Lange; Huaisheng Xu; Wolfgang Henrich; Joachim W Dudenhausen; Andreas Plagemann; John P Newnham; John R G Challis
Journal:  Reprod Sci       Date:  2014-07-25       Impact factor: 3.060

Review 3.  Fetal drug therapy.

Authors:  M I Evans; P G Pryde; A Reichler; M Bardicef; M P Johnson
Journal:  West J Med       Date:  1993-09

4.  Successful prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  S A Wudy; J Homoki; W M Teller
Journal:  Eur J Pediatr       Date:  1994-08       Impact factor: 3.183

5.  TaqI HLA-B and -DRB RFLP analysis can predict disease in siblings of affected children with 21-hydroxylase deficiency.

Authors:  O Olerup; H Luthman; E M Ritzén; B Haglund-Stengler
Journal:  Hum Genet       Date:  1990-10       Impact factor: 4.132

6.  Mutations in the CYP11B1 gene causing congenital adrenal hyperplasia and hypertension cluster in exons 6, 7, and 8.

Authors:  K M Curnow; L Slutsker; J Vitek; T Cole; P W Speiser; M I New; P C White; L Pascoe
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.